This formulation, also known as Paclitaxel for Injection (Albumin Bound), has demonstrated the ability to enhance the anti-tumor effectiveness of PTX while simultaneously reducing the associated side effects (Fan and He, 2022). Here, ALB is linked to neoplasm.